For instance, studies have demonstrated that the genetic deletion or pharmacological inhibition of NPC1L1 reduces hepatic cholesterol content and ameliorates liver steatosis in high-fat diet (HFD)-fed NAFLD mice [13,14]. The gene discussed is NPC1L1; the disease is fatty liver disease.